Irritable bowel syndrome is a very urgent problem in modern gastroenterology. A deeper understanding of the ethology and pathogenesis, variety drugs for treatment IBS gives hope possibility effective control over disease near future. The article provides brief overview latest advances study irritable syndrome, which were reported at next UEG Week Virtual 2020, held October 2020.

conclusions the results of the study were indicative of improvement and symptom relief in the majority of patients and it seems that treatment prolongation up to six months could be a key factor to achieve better clinical responses. it is recommended that further randomized clinical trials evaluate this therapeutic regimen. background the current study aimed to evaluate the efficacy of mesalazi...

normal 0 false false false en-us x-none ar-sa microsoftinternetexplorer4 background: the prevalence of irritable bowel syndrome (ibs) in the community is 10%–20% and have symptom based diagnostic criteria. many symptoms of celiac disease (cd) with 1% prevalence in some communities can mimic ibs. sensitive and specific serologic tests of cd can detect asymptomatic cases. the purpose of this stud...

the main inflammatory bowel disorders are including celiac disease (cd), inflammatory bowel diseases (ibd) and irritable bowel syndrome (ibs). celiac disease is a digestive and autoimmune disorder that can damage the small intestine and characterized by a multitude gastrointestinal (gi) and extra gi symptoms. ibd (including ulcerative colitis and crohn’s disease) is a group of inflammatory cond...

BACKGROUND Patients diagnosed with irritable bowel syndrome may have coeliac disease. AIM To evaluate the cost-effectiveness of coeliac disease testing in suspected irritable bowel syndrome. METHODS We used decision analysis to estimate the number of coeliac disease cases detected, quality-adjusted life-years gained, and costs resulting from testing suspected irritable bowel syndrome patien...

The use of alternative medicine was assessed by questionnaire in 96 patients with irritable bowel syndrome, 143 patients with organic upper gastrointestinal disorders and 222 patients with Crohn's disease of comparable age and sex. Significantly more patients with the irritable bowel syndrome (16%) had consulted practitioners of alternative medicine about their condition than had patients in ei...

BACKGROUND In secondary care, irritable bowel syndrome (IBS) is frequently associated with non-colonic symptoms including lethargy, backache and chest pains which can result in inappropriate referral to different specialities with the condition remaining unrecognised. This could also be a problem in the elderly where comorbidity is common, especially as irritable bowel syndrome is usually assoc...